Skip to main content

Table 2 Patient characteristics of conversion surgery group and chemotherapy alone group

From: Prognostic benefit of conversion surgery for HER2 positive stage IV gastric cancer; a case series study of eleven patients treated with trastuzumab-based chemotherapy

Patient demographics

Variables

Conversion surgery

Chemotherapy alone

Sex

Male/female

5/1

3/2

Age

Median/range

65.0/61–68

64.0/43–78

Liver metastasis

Positive/negative

3/3

3/2

Distant metastasis (except liver)

Positive/negative

0/6

4/1

Lymph node metastasis

Regional/not regional

0/6

3/3

Peritoneal metastasis

P1/P0 and CY1/P0

1/2/3

2/0/3

Number of stage IV factor

Less than 2/3 factors

6/0

3/2

  1. P1 peritoneal metastasis, CY peritoneal cytology